Orpea’s challenge to its business model leads us to cut our forecasts in addition to valuation parameters (see 26-01-2022). It is clearly a double-whammy. The new target price is certainly not encompassing the distinct possibility that the crisis is a protracted one for the whole senior care industry leading to a structural drop in margins nor does it account for a change in governance.
